Last reviewed · How we verify

NCT06227000: LLS

Living Longer and Stronger With Spinal Cord Injury (SCI)

Active, enrolled NA Last updated 1 December 2025
What this trial tests

NA trial testing Living Longer and Stronger with SCI in Spinal Cord Injuries in 180 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
13 February 2024
Primary endpoint
1 July 2026
1 July 2026

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment180
Start date13 February 2024
Primary completion1 July 2026
Estimated completion1 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop a health promotion group intervention to meet the unique health promotion needs of people aging with SCI, to test the efficacy of the adapted intervention program, Living Longer and Stronger with SCI, in a randomized controlled trial and to assess the mechanisms through which the intervention may enhance physical, psychological, and social health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06227000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing